Clinical Trial Update: Safety and Efficacy Study of Eptifibatide in Primary Percutaneous Coronary Intervention (PCI) [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update assessing the safety and efficacy of eptifibatide during primary percutaneous coronary intervention in patients with myocardial …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Drugs mentioned

• Integrilin (Eptifibatide)

Snippet

Sponsor: Ottawa Heart Institute Research Corporation | Conditions: Myocardial Infarction | Phase 3 | Status: COMPLETED